Results 191 to 200 of about 45,032 (221)

Irinotecan

Reactions Weekly, 2012
openaire   +2 more sources

Irinotecan

Reactions Weekly, 2016
  +4 more sources

Irinotecan

Reactions Weekly, 2000
openaire   +1 more source

Irinotecan

Reactions Weekly, 2022
openaire   +2 more sources

Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)

Annals of Oncology, 2015
Y Kakeji, M Kochi
exaly  

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Annals of Oncology, 2009
G Lledo, M Mabro, A Figer
exaly  

Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview

International Journal of Molecular Sciences, 2020
Beata Marciniak, Mateusz Kciuk, Renata Kontek   +2 more
exaly  

Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I–II study

Annals of Oncology, 2007
David Cunningham, Tamás Hickish, Richard H Osborne   +2 more
exaly  

Clinical and pharmacogenetic factors associated with irinotecan toxicity

Cancer Treatment Reviews, 2008
Hans Gelderblom, Henk-Jan Guchelaar
exaly  

Irinotecan

Reactions Weekly, 2003
openaire   +3 more sources